Ellsworth Advisors’s Hims & Hers Health HIMS Stock Holding History

Ellsworth Advisors’s Portfolio HIMS Stock Details HIMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-13,910	Closed	-$693K	–	179
2025 Q2	$693K	Buy	+13,910	New	+$629K	0.17%	114

Other funds holding HIMS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ellsworth Advisors's HIMS Position: Q3 2025 in Review

Ellsworth Advisors sold out of Hims & Hers Health (HIMS) in Q3 2025, closing a stake of 13,910 shares — an estimated $693K sold.

Ellsworth Advisors first reported a position in HIMS in Q2 2025 and held it in 1 quarter. The position peaked at $693K in Q2 2025. 512 funds tracked by Wall St. Rank hold HIMS as of Q3 2025.

Ellsworth Advisors reported no remaining Hims & Hers Health position as of Q3 2025 after selling out during the quarter.
Ellsworth Advisors sold 13,910 Hims & Hers Health shares in Q3 2025, an estimated $693K.
Ellsworth Advisors first reported a position in Hims & Hers Health in Q2 2025 and held it in 1 quarter.
Ellsworth Advisors's Hims & Hers Health position peaked at $693K in Q2 2025.
512 funds tracked by Wall St. Rank held Hims & Hers Health as of Q3 2025.

Based on Ellsworth Advisors's 13F filing for Q3 2025, filed 16 Oct 2025.